英文名稱: |
(2R,3aR,10Z,11aS,12aR,14aR)-N-(Cyclopropylsulfonyl)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydro-2-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]-5-methyl-4,14-dioxocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1 |
英文別名: |
TMC-435350;TMC435;(2R,11aS,12aR,14aR,Z)-N-(cyclopropylsulfonyl)-2-((2-(4-isopropylthiazol-2-yl)-7-methoxy-8-methylquinolin-4-yl)oxy)-5-methyl-4,14-dioxo-1,2,3,3a,4,5,6,7,8,9,11a,12,12a,13,14,14a-hexadecahydrocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a-carboxamide;TMC 435350;simprevir;Simeprivir;Olysio (TN);(2R,3aR,10Z,11aS,12aR,14aR)-N-(Cyclopropylsulfonyl)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydro-2-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]-5-methyl-4,14-dioxocyc;Simeprevir;(2R,3aR,10Z,11aS,12aR,14aR)-N-(Cyclopropylsulfonyl)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydro-2-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]-5-methyl-4,14-dioxocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1 |
中文別名: |
西米普韋中間體;西米普韋;司美匹韋;Simeprevir標(biāo)準(zhǔn)品;Simeprevir(TMC 435350) 抑制劑;(2R,3AR,10Z,11AS,12AR,14AR)-N-(環(huán)丙基磺?;?-2,3,3A,4,5,6,7,8,9,11A,12,13,14,14A-十四氫-2-[[7-甲氧基-8-甲基-2-[4-(1-甲基乙基)-2-噻唑基]-4-喹啉;(2R,3aR,10Z,11aS,12aR,14aR)-N-(環(huán)丙基磺?;?-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-十四氫-2-[[7-甲氧基-8-甲基-2-[4-(1-甲基乙基)-2-噻唑基]-4-喹啉基]氧基]-5-甲基-4,14-二氧代環(huán)戊并[c]環(huán)丙并[g][1,6]二氮雜環(huán)十四烯-12a(1H)-甲酰胺 |
CAS No.: |
923604-59-5 |
分子式: |
C38H47N5O7S2 |
分子量: |
749.94 |
純度: |
98% |